Latest Breaking News On - Division of renal kidney medicine at brigham - Page 1 : vimarsana.com

SGLT2 Inhibitors Reduce Kidney Stone Risk in Type 2 Diabetes

Patients with type 2 diabetes treated with SGLT2 inhibitors vs other common diabetes drugs show up to a 31% reduced risk of kidney stone development.

Kidney stones: Type 2 diabetes medication may help lower risk

A type of medication used to treat type 2 diabetes could help lower the risk of developing kidney stones, a new study suggests.

Kidney stone risk is lowered by a class of diabetes medications: Study

The study shows that sodium-glucose contratransporter 2 (SGLT2) inhibitors can reduce the risk of acquiring kidney stones. | Health

Kidney stone risk is lowered by a class of diabetes medications: Study

Diabetes Drug Can Cut Risk of Kidney Stones

Discover the potential of SGLT2 inhibitors- a class of diabetes drugs, in mitigating kidney stones risk in diabetic patients.